Aethlon Medical Stock Forecast for 2023 - 2025 - 2030
Updated on 05/02/2024
Aethlon Medical Stock Forecast and Price Target
Aethlon Medical's most recent price target of $25.05 for 2024 was provided by renowned analysts over the past few months, with an average prediction of $25.05. If this prediction is correct, Aethlon Medical's stock could rise by 1728.47 percent from its current trading price. The potential increase for the stock is $25.05 per share, with a possible range of $10.00 to $40.10. If you're thinking of investing in AEMD stock, it might be good to look at its rivals too.
1728.47% Upside
Aethlon Medical Fair Value Forecast for 2023 - 2025 - 2030
Aethlon Medical's Price has increased by 100.00% In the last five years, going from $0.00 to $0.00. In the next year, analysts expect Fair Value to reach $1.51 – an increase of 100.00%. For the next six years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BDX Stock Forecast | Becton Dickinson and Co | Outperform |
9
|
$240.35 | Buy/Sell | $284.47 | 15.46% |
| ABMD Stock Forecast | Abiomed | - |
16
|
$377.79 | Buy/Sell | $380.00 | -88.33% |
| TFX Stock Forecast | Teleflex Inc | Hold |
13
|
$198.73 | Buy/Sell | $263.46 | 33.35% |
| PEN Stock Forecast | Penumbra | Outperform |
9
|
$206.06 | Buy/Sell | $258.62 | 39.30% |
| GMED Stock Forecast | Globus Medical | Outperform |
16
|
$50.48 | Buy/Sell | $64.58 | 18.86% |
Aethlon Medical Revenue Forecast for 2023 - 2025 - 2030
Aethlon Medical's Revenue has decreased by 12.31% In the last three years, from $650.00k to $570.00k. In the next year, analysts expect Revenue to reach $800.00k – an increase of 40.35%. For the next six years, the forecast is for Revenue to grow by 39.68%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GKOS Stock Forecast | Glaukos | Outperform |
7
|
$105.03 | Buy/Sell | $87.33 | 2.83% |
| HAE Stock Forecast | Haemonetics | Outperform |
16
|
$93.33 | Buy/Sell | $70.17 | 12.50% |
| MMSI Stock Forecast | Merit Medical Systems | Outperform |
14
|
$77.02 | Buy/Sell | $89.25 | 14.26% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| NARI Stock Forecast | Inari Medical | Outperform |
14
|
$41.99 | Buy/Sell | $82.67 | 54.80% |
| ICUI Stock Forecast | ICU Medical | Outperform |
16
|
$99.04 | Buy/Sell | $153.50 | 37.82% |
| NUVA Stock Forecast | NuVasive | - |
14
|
$4.86 | Buy/Sell | $73.81 | -100.00% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| LMAT Stock Forecast | LeMaitre Vascular | Outperform |
18
|
$66.77 | Buy/Sell | $59.86 | 7.83% |
| APR Stock Forecast | Apria | - |
16
|
$37.50 | Buy/Sell | $37.50 | -100.00% |
| ATRC Stock Forecast | AtriCure | Buy |
8
|
$22.22 | Buy/Sell | $55.00 | 156.53% |
Aethlon Medical EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Aethlon Medical's EBITDA has grown from $-5.90M to $-11.66M – a 97.63% increase. For the next year, 0 analysts project Aethlon Medical's EBITDA to drop by 20.10%, reaching $-9.32M. By 2030, professionals believe that Aethlon Medical's EBITDA will decrease by 17.69%, reaching $-9.60M – a concerning trend for the company.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ATRI Stock Forecast | Atrion | - |
18
|
$352.20 | Buy/Sell | $946.00 | -100.00% |
| IRMD Stock Forecast | IRadimed | Buy |
16
|
$43.85 | Buy/Sell | $60.00 | 42.53% |
| OFIX Stock Forecast | Orthofix Medical | Hold |
10
|
$13.24 | Buy/Sell | $18.00 | 13.29% |
Aethlon Medical EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Aethlon Medical's EBIT has grown by 100.67%, rising from $-5.93M to $-11.90M. For next year, analysts predict EBIT of $-16.28M, which would mean an increase of 36.81%. Over the next six years, experts predict that Aethlon Medical's EBIT will grow at a rate of 12.88%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MON Stock Forecast | Misonix | - |
7
|
$26.54 | Buy/Sell | $28.00 | -100.00% |
| LYRA Stock Forecast | Lyra Therapeutics | Buy |
4
|
$4.63 | Buy/Sell | $11.80 | 159.18% |
| LUNG Stock Forecast | Pulmonx | Outperform |
4
|
$9.38 | Buy/Sell | $15.33 | 70.58% |
Aethlon Medical EPS Price Prediction Forecast for 2023 - 2025 - 2030
Aethlon Medical's EPS has increased by 100.00% In the last five years, going from $-17.51 to $0.00. In the next year, analysts expect EPS to reach $-6.60 – an increase of 100.00%. For the next six years, the forecast is for EPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SGHT Stock Forecast | Sight Sciences | Hold |
5
|
$5.61 | Buy/Sell | $3.88 | -6.42% |
| APEN Stock Forecast | Apollo Endosurgery | - |
10
|
$10.00 | Buy/Sell | $0.00 | -100.00% |
| ANGO Stock Forecast | AngioDynamics | Buy |
8
|
$6.08 | Buy/Sell | $16.33 | 113.82% |
.jpg)